Skandinaviska Enskilda Banken AB (publ)

Position in RNA — Atrium Therapeutics, Inc.

CIK 1534653 STOCKHOLM, V7

Position in RNA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$59,180

New position

Shares Held

4,400

first reported quarter

Ownership

0.026%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#97

of 155 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Skandinaviska Enskilda Banken AB (publ) holds $13,866,735 across 5 Biotechnology names. RNA ranks #4 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,000	$11,424,790
2	APGE	Apogee Therapeutics, Inc.	10,500	$1,393,665
3	TECH	BIO-TECHNE Corp	14,000	$989,100
4	RNA	Atrium Therapeutics, Inc. This page	4,400	$59,180
5			20,500	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$59,180	4,400	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.